Keywords: Astellas, Evec, Antibody, Infectious diseases, Mitsubishi Tanabe, Synageva, Orphan diseases

Astellas in-licenses antibody from Evec; Mitsubishi Tanabe deal with Synageva

Article | 06 September 2011

Print This

Japanese biotech firm Evec has entered a license agreement for one of its fully-human antibodies against infectious diseases with domestic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in